Marty St. Clair

5.5k total citations
66 papers, 2.9k citations indexed

About

Marty St. Clair is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Marty St. Clair has authored 66 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 46 papers in Virology and 11 papers in Epidemiology. Recurrent topics in Marty St. Clair's work include HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (46 papers) and HIV/AIDS Research and Interventions (27 papers). Marty St. Clair is often cited by papers focused on HIV Research and Treatment (46 papers), HIV/AIDS drug development and treatment (46 papers) and HIV/AIDS Research and Interventions (27 papers). Marty St. Clair collaborates with scholars based in United States, United Kingdom and Canada. Marty St. Clair's co-authors include Daniel McClernon, Daniel R. Kuritzkes, E. Randall Lanier, Michael M. Lederman, Harold A. Kessler, Alan Landay, Elizabeth Connick, Justin C. McArthur, Michael F. Cronin and T. E. Nance‐Sproson and has published in prestigious journals such as Environmental Science & Technology, The Science of The Total Environment and Neurology.

In The Last Decade

Marty St. Clair

64 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marty St. Clair United States 27 1.9k 1.9k 609 354 277 66 2.9k
Mark Underwood United States 25 1.7k 0.9× 1.9k 1.0× 871 1.4× 239 0.7× 642 2.3× 55 2.8k
Hua Guo China 22 532 0.3× 268 0.1× 251 0.4× 135 0.4× 515 1.9× 91 2.3k
Xiang He China 25 1.1k 0.6× 1.0k 0.5× 541 0.9× 30 0.1× 261 0.9× 98 1.9k
Louis Alexander United States 30 932 0.5× 979 0.5× 560 0.9× 42 0.1× 547 2.0× 68 3.1k
David Stone United States 16 630 0.3× 256 0.1× 152 0.2× 174 0.5× 131 0.5× 30 1.4k
Joe L. Griffin United States 17 191 0.1× 367 0.2× 244 0.4× 181 0.5× 551 2.0× 29 1.5k
David Oldach United States 29 287 0.2× 450 0.2× 1.8k 3.0× 48 0.1× 806 2.9× 86 4.2k
J R Harris United Kingdom 20 128 0.1× 317 0.2× 544 0.9× 80 0.2× 122 0.4× 80 1.4k
Ye Ma China 23 655 0.3× 1.1k 0.6× 585 1.0× 223 0.6× 35 0.1× 71 1.6k
J.J. González Spain 28 60 0.0× 124 0.1× 176 0.3× 71 0.2× 160 0.6× 84 2.3k

Countries citing papers authored by Marty St. Clair

Since Specialization
Citations

This map shows the geographic impact of Marty St. Clair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marty St. Clair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marty St. Clair more than expected).

Fields of papers citing papers by Marty St. Clair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marty St. Clair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marty St. Clair. The network helps show where Marty St. Clair may publish in the future.

Co-authorship network of co-authors of Marty St. Clair

This figure shows the co-authorship network connecting the top 25 collaborators of Marty St. Clair. A scholar is included among the top collaborators of Marty St. Clair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marty St. Clair. Marty St. Clair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fogel, Jessica M., Vanessa Cummings, Heba H. Mostafa, et al.. (2024). Evaluation of Xpert point-of-care assays for detection of HIV infection in persons using long-acting cabotegravir for pre-exposure prophylaxis. Microbiology Spectrum. 12(8). e0030724–e0030724. 3 indexed citations
2.
Schilling, Keith E., et al.. (2023). Effects of cattle manure and soil parent material on shallow groundwater quality. Agrosystems Geosciences & Environment. 6(3).
3.
Schilling, Keith E., et al.. (2021). Aquifer lithology affects shallow groundwater quality more than nitrogen fertilizer form and placement method in an Iowa agricultural field. Agrosystems Geosciences & Environment. 4(2). 2 indexed citations
4.
Schilling, Keith E., Peter J. Jacobson, Marty St. Clair, & Christopher S. Jones. (2020). Dissolved phosphate concentrations in Iowa shallow groundwater. Journal of Environmental Quality. 49(4). 909–920. 13 indexed citations
5.
Demarest, James F., Mark Underwood, Marty St. Clair, et al.. (2018). Short Communication: Dolutegravir-Based Regimens Are Active in Integrase Strand Transfer Inhibitor–Naive Patients with Nucleoside Reverse Transcriptase Inhibitor Resistance. AIDS Research and Human Retroviruses. 34(4). 343–346. 16 indexed citations
6.
Schilling, Keith E., et al.. (2018). Subsurface nutrient processing capacity in agricultural roadside ditches. The Science of The Total Environment. 637-638. 470–479. 11 indexed citations
7.
Spreen, William, Sherene Min, Susan L. Ford, et al.. (2013). Pharmacokinetics, Safety, and Monotherapy Antiviral Activity of GSK1265744, an HIV Integrase Strand Transfer Inhibitor. HIV Clinical Trials. 14(5). 192–203. 92 indexed citations
8.
Stellbrink, Hans-Jürgen, Jacques Reynes, Adriano Lazzarin, et al.. (2013). Dolutegravir in antiretroviral-naive adults with HIV-1. AIDS. 27(11). 1771–1778. 131 indexed citations
9.
Elion, Richard, Edwin DeJesus, Michael Sension, et al.. (2008). Once-Daily Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir for the Treatment of HIV-1 Infection in Antiretroviral-Naïve Patients: A 48-Week Pilot Study. HIV Clinical Trials. 9(3). 152–163. 21 indexed citations
10.
McClernon, Daniel, Cindy Vavro, & Marty St. Clair. (2006). Evaluation of a Real-Time Nucleic Acid Sequence-Based Amplification Assay Using Molecular Beacons for Detection of Human Immunodeficiency Virus Type 1. Journal of Clinical Microbiology. 44(6). 2280–2282. 15 indexed citations
11.
Ruane, Peter, Edwin DeJesus, Daniel S Berger, et al.. (2006). Pilot Study of Once-Daily Simplification Therapy with Abacavir/Lamivudine/Zidovudine and Efavirenz for Treatment of HIV-1 Infection. HIV Clinical Trials. 7(5). 229–236. 8 indexed citations
12.
13.
Liao, Qiming, et al.. (2002). Genotypic and Phenotypic Cross-Resistance Patterns to Lopinavir and Amprenavir in Protease Inhibitor-Experienced Patients with HIV Viremia. AIDS Research and Human Retroviruses. 18(14). 1011–1019. 21 indexed citations
14.
15.
16.
17.
Haas, David W., James P. Lavelle, Jeffrey P. Nadler, et al.. (2000). A Randomized Trial of Interferon alpha Therapy for HIV Type 1 Infection. AIDS Research and Human Retroviruses. 16(3). 183–190. 42 indexed citations
18.
Lederman, Michael M., Elizabeth Connick, Alan Landay, et al.. (1998). Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315. The Journal of Infectious Diseases. 178(1). 70–79. 354 indexed citations
19.
McArthur, Justin C., Daniel McClernon, Michael F. Cronin, et al.. (1997). Relationship between human immunodeficiency virus—associated dementia and viral load in cerebrospinal fluid and brain. Annals of Neurology. 42(5). 689–698. 321 indexed citations
20.
Painter, George R., et al.. (1995). 524W91. Anti-HIV, Anti-hepatitis B virus. Drugs of the Future. 20(8). 761–765. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark Underwood Breakdown of academic impact, for papers by Hua Guo Breakdown of academic impact, for papers by Xiang He Breakdown of academic impact, for papers by Louis Alexander Breakdown of academic impact, for papers by David Stone Breakdown of academic impact, for papers by Joe L. Griffin Breakdown of academic impact, for papers by David Oldach Breakdown of academic impact, for papers by J R Harris Breakdown of academic impact, for papers by Ye Ma Breakdown of academic impact, for papers by J.J. González
Rankless by CCL
2026